JENNIFER COPPER: Open Payments
NPI 1669882742 · BRASELTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$915 in 47 payments from 15 companies in 2025. Trend: 2023 $1,012 · 2024 $882 · 2025 $915
Food & beverage: $915
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $390 |
| Lilly USA, LLC | 4 | $82 |
| SHIELD THERAPEUTICS INC | 3 | $68 |
| PFIZER INC. | 4 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $55 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $32 |
| Lundbeck LLC | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
Products named: Ozempic, Wegovy, MOUNJARO, REXULTI, ACCRUFER, AIRSUPRA, Auvelity, NURTEC ODT.
Industry payments across GA — which companies pay providers there.
